Dermata Therapeutics Number Of Employees vs. Number Of Shares Shorted

DRMAW Stock  USD 0.01  0  19.57%   
Based on Dermata Therapeutics' profitability indicators, Dermata Therapeutics Warrant may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Dermata Therapeutics' ability to earn profits and add value for shareholders. At this time, Dermata Therapeutics' Shareholders Equity Per Share is fairly stable compared to the past year. Graham Net Net is likely to climb to 31.50 in 2024, despite the fact that Operating Cash Flow Per Share is likely to grow to (31.38).
For Dermata Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Dermata Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Dermata Therapeutics Warrant utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Dermata Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Dermata Therapeutics Warrant over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
For more information on how to buy Dermata Stock please use our How to Invest in Dermata Therapeutics guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermata Therapeutics. If investors know Dermata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.16)
Return On Assets
(0.91)
Return On Equity
(1.73)
The market value of Dermata Therapeutics is measured differently than its book value, which is the value of Dermata that is recorded on the company's balance sheet. Investors also form their own opinion of Dermata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dermata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermata Therapeutics' market value can be influenced by many factors that don't directly affect Dermata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Dermata Therapeutics Number Of Shares Shorted vs. Number Of Employees Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Dermata Therapeutics's current stock value. Our valuation model uses many indicators to compare Dermata Therapeutics value to that of its competitors to determine the firm's financial worth.
Dermata Therapeutics Warrant is rated # 5 in number of employees category among its peers. It also is rated # 5 in number of shares shorted category among its peers making about  150.00  of Number Of Shares Shorted per Number Of Employees. Comparative valuation analysis is a catch-all technique that is used if you cannot value Dermata Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Dermata Number Of Employees vs. Competition

Dermata Therapeutics Warrant is rated # 5 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 46.0. Dermata Therapeutics retains roughly 8.0 in number of employees claiming about 17% of equities under Health Care industry.

Dermata Number Of Shares Shorted vs. Number Of Employees

Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Dermata Therapeutics

Number of Employees

 = 

Full Time

+

Part Time

 = 
8
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Dermata Therapeutics

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
1.2 K
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

Dermata Number Of Shares Shorted Comparison

Dermata Therapeutics is currently under evaluation in number of shares shorted category among its peers.

Dermata Therapeutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Dermata Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Dermata Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Dermata Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Dermata Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-47.7 M-50.1 M
Net Interest Income203.4 K213.6 K
Operating Income-8 M-8.4 M
Net Loss-7.3 M-7.7 M
Income Before Tax-7.8 M-8.2 M
Total Other Income Expense Net247.2 K259.6 K
Net Loss-7.8 M-8.2 M
Income Tax Expense-8 K-7.6 K
Interest Income247.2 K170.9 K
Net Loss(40.18)(38.17)
Income Quality 0.82  1.00 
Net Income Per E B T 1.16  1.14 

Dermata Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Dermata Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Dermata Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Dermata Therapeutics' important profitability drivers and their relationship over time.

Use Dermata Therapeutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dermata Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Dermata Therapeutics Pair Trading

Dermata Therapeutics Warrant Pair Trading Analysis

The ability to find closely correlated positions to Dermata Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dermata Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dermata Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dermata Therapeutics Warrant to buy it.
The correlation of Dermata Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dermata Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dermata Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dermata Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Dermata Therapeutics position

In addition to having Dermata Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Office Supplies Thematic Idea Now

Office Supplies
Office Supplies Theme
Companies producing and selling office supplies, and accessories. The Office Supplies theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Office Supplies Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Dermata Stock Analysis

When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.